Life Sciences

Fast or Defensible: Pick One, or Pick Komodo

Life Sciences teams are forced to choose between fast answers and an answer they can stand behind. Komodo delivers both, in minutes, with an audit trail.

See It in Action

Commercial

  • Answers in minutes, not weeks
    The launch question that took three weeks takes minutes. Marmot runs the analysis. Act on the answer the same day.
  • See what’s shifting
    Prescribing, patient, and payer signals linked and fresh daily. Every decision built on what’s true today.
  • Target with precision
    Segment HCPs, prioritize accounts, and map referral networks on real prescribing behavior, not assumptions.

Answer Your Launch Questions

How have GLP-1 launches and label expansions shifted market share?
Show me 6 month pre/post HCRU and cost patterns for multiple myeloma patients undergoing autologous stem cell transplant

HEOR/RWE

  • Evidence you can defend
    Built for research rigor. Unified visits, continuous enrollment, complete cost data. Not retrofitted claims data.
  • Methodology you own
    Your cohorts, codesets, and methods saved, versioned and reusable. Be audit-ready, for every single study.
  • More questions, same budget
    Cohort identification in minutes. Get descriptive statistics in a day, not months. Same rigor. No new scope or budget.

Discuss Your HEOR Study

Medical Affairs

  • Start where studies stop
    Publications show what should happen. See the patterns, diagnosis gaps, and treatment switches that tell a different story.
  • Answers you can defend
    Ground every scientific narrative in real patient data. Walk in with evidence that earns the conversation.
  • Measure practice change
    Know whether your education moved practice. Real-world insights make physician behavior change visible, not assumed.

See Komodo for Medical Affairs

Show me the top 10 ophthalmologists treating leber hereditary optic neuropathy patients in california by volume
Map the treatment pathway for multiple sclerosis patients from diagnosis through third-line therapy

Clinical Development

  • Design for real patients
    Most inclusion criteria are written against assumptions. Marmot shows you how patients actually present before the protocol locks.
  • Pick sites that enroll
    See sites with the patients, specialists, and referral patterns to hit your targets. Pick on evidence, not relationships.
  • Hit enrollment for once
    80% of trials miss enrollment.¹ Know where patients are by geography, specialty, and payer. Stop guessing.

Book Your Clinical Demo

¹ Desai M. Recruitment and retention of participants in clinical studies: Critical issues and challenges. Perspectives in Clinical Research. 2020;11(2):64-69.

Analytics and AI Teams

  • One platform. Not five.
    Most Life Sciences AI is a patchwork of models, data, and outputs. Komodo runs on one foundation for a shared truth.
  • AI you can explain
    Marmot’s transparent methodology and traceable logic allow your governance team to review outputs and regulators to audit results.
  • Move past the pilot
    Fragmented AI stays in pilot forever. Run commercial, HEOR, and clinical insights on one platform, at scale.

Build Your AI Strategy

cursor query

“Komodo’s clinical alerts have revolutionized our way of doing business. We have relevant, accurate information at the precise moment we need it for our conversations with providers.”

VP of Sales· Large Biopharma

Bring the Question Your Team Is Stuck On

The best way to know if Komodo works for you is to ask a real question. The launch readout, the KOL plan, the evidence gap, the feasibility study. We will show you how the platform answers it, with methodology your compliance team can audit.

Talk to an Expert